2026 Oculoplastic Surgeon Salary Guide: Ophthalmic Plastic Surgery Compensation

Oculoplastic surgery — formally Ophthalmic Plastic and Reconstructive Surgery (OPRS), governed by ASOPRS (American Society of Ophthalmic Plastic and Reconstructive Surgery) — is a subspecialty of ophthalmology focused on the eyelids, orbit, lacrimal system, and periocular aesthetic surgery. The specialty occupies a unique position in medicine: it combines high-volume functional procedures (ptosis repair, ectropion/entropion correction, tear duct surgery) with one of the fastest-growing cash-pay aesthetic markets in medicine (blepharoplasty is among the most searched cosmetic procedures for patients over 50). Total compensation in 2026 ranges from $350,000 to $900,000+ depending on practice model, cash-pay mix, and market demographics.

Salary overview by practice setting

• Academic ophthalmology department (ASOPRS training program): $300,000–$500,000; fellowship training responsibilities; NIH NEI funding potential; PSLF-eligible employment; research protected time; Wills Eye, Bascom Palmer, Kellogg, Mass Eye and Ear, and Jules Stein anchor the academic training landscape
• Hospital-employed or large ophthalmology group (functional + cosmetic mix): $380,000–$580,000; wRVU model for functional procedures; self-pay pricing for cosmetic cases; employer captures facility fee; no ownership benefit; strong referral network from ophthalmology partners driving functional volume
• Private oculoplastic practice (functional + cosmetic): $500,000–$850,000; full professional fee retention; cosmetic procedures priced at market rate; orbital and complex reconstructive referrals from ophthalmology, dermatology (Mohs), otolaryngology, and trauma surgery; ASC or in-office procedure room ownership adds technical fee
• High-volume cosmetic oculoplastics (aesthetics-dominant practice): $700,000–$1,200,000+; blepharoplasty as core surgical offering + Botox + filler + periorbital aesthetics; med-spa integration; social media marketing of results (periorbital rejuvenation is highly photogenic); target demographic (patients 45–70 with insurance-adjacent cosmetic concerns) is ideal for hybrid billing

Fellowship pathway

ASOPRS requires a 2-year accredited fellowship from a completed ophthalmology residency (4 years post-MD). ASOPRS certification requires submission of a surgical case log (minimum 200 cases across defined procedure categories), written and oral examination. Approximately 120–150 ASOPRS fellows graduate annually. The supply constraint is meaningful — every ophthalmology department and large multi-subspecialty ophthalmology group wants at least one ASOPRS-trained surgeon, and the fellowship pipeline trains fewer graduates than the market demands.

Procedures and CPT billing

• Upper eyelid blepharoplasty (functional): CPT 15822 (unilateral) or 15823 (with skin redundancy only); professional fee $1,500–$3,000 per eye (bilateral = CPT 15822 × 2 or 15823 × 2); insurance-covered when visual field defect documented on Humphrey visual field testing with ptotic lids taped (pre-op) and untaped (post-op) comparison; Medicare criteria require superior visual field improvement ≥12° when upper eyelid margin obscures the pupil; the insurance billing pathway creates a hybrid model: functional blepharoplasty is among the highest-volume reimbursed procedures in oculoplastic surgery
• Upper eyelid blepharoplasty (cosmetic): Self-pay; surgeon fee $2,500–$5,000 per session (bilateral); the functional-to-cosmetic triage is a core skill in oculoplastics — patients who present cosmetically may qualify for insurance-covered functional repair if criteria are met, while purely cosmetic patients proceed on self-pay pricing
• Lower eyelid blepharoplasty: CPT 15820 (lower, without fat removal) / 15821 (lower, with fat removal); professional fee $2,000–$4,500 (self-pay only — no insurance coverage for lower blepharoplasty); combined upper + lower blepharoplasty (quad-lid) is the highest-volume combined aesthetic oculoplastic case
• Ptosis repair — levator advancement or resection: CPT 67904 (levator resection or advancement); professional fee $2,000–$4,000; 5.1 wRVU; insurance-covered for functional ptosis (pupillary obstruction or margin-reflex distance ≤2mm on primary gaze); most common reconstructive oculoplastic procedure in practice; congenital ptosis (CPT 67901) and frontalis suspension (CPT 67906) are additional ptosis code variants for severe or congenital cases
• Ectropion repair: CPT 67914 (suture) or 67916 (excisional) or 67917 (extensive); professional fee $1,500–$3,500; eyelid outturning (ectropion) causing exposure keratopathy and tearing; insurance-covered; steady volume from aging population
• Entropion repair: CPT 67921 (suture) or 67923 (tarsal wedge excision) or 67924 (tarsal margin rotation); professional fee $1,500–$3,500; eyelid inturning causing corneal irritation from lashes; insurance-covered
• Chalazion excision: CPT 67800 (single, without general anesthesia); professional fee $400–$800; minor office procedure; insurance-covered; high-volume bread-and-butter oculoplastic procedure; multiple chalazia in one session billed with appropriate modifiers (67801/67808); often performed under topical/local in-office procedure room
• Eyelid reconstruction post-Mohs: CPT 67961 (repair of eyelid, one-fourth of lid margin) through 67966; professional fee $2,000–$5,000 depending on complexity; reconstruction of periocular skin cancer defects after Mohs micrographic surgery; steady referral from dermatology Mohs surgeons; complex reconstructive cases (full-thickness eyelid loss, canthal reconstruction) generate high wRVU and significant professional fees
• Lacrimal duct surgery — dacryocystorhinostomy (DCR): CPT 68720 (external DCR); professional fee $2,500–$4,500; bypass surgery for blocked nasolacrimal duct causing recurrent dacryocystitis and epiphora; endoscopic DCR (CPT 68761 — nasolacrimal duct probe + dilation, or endonasal approach codes in ENT/ophthalmology crossover); insurance-covered; collaboration with ENT for endonasal approach
• Orbital decompression: CPT 67414 (removal of bone from orbit) or 67445 (orbital fat removal); professional fee $3,500–$7,000; Graves' disease thyroid eye disease (TED) with compressive optic neuropathy or disfiguring proptosis; high complexity; significant wRVU; growing market with teprotumumab (Tepezza) infusion therapy for TED expanding the treatment landscape and driving oculoplastic consultation volume
• Orbital tumor excision: CPT 67400–67430 range; professional fee $3,000–$7,000 depending on approach and depth; anterior vs. lateral vs. medial orbitotomy; dermoid cyst, cavernous hemangioma, lacrimal gland tumor; rare but high-complexity referrals drive program reputation
• Botulinum toxin for blepharospasm / hemifacial spasm: CPT 64615 (chemodenervation of facial muscles, bilateral); professional fee $500–$1,000; buy-and-bill on J0585 (onabotulinumtoxinA per unit) — therapeutic Botox for blepharospasm is insurance-covered under neurology and ophthalmology; separate from cosmetic Botox; recurring every 3–4 months; creates durable patient relationships and recurring revenue stream

Cash-pay aesthetics and med-spa integration

Oculoplastic surgeons occupy an advantageous position in the periorbital aesthetics market because they can offer both functional insurance-covered procedures and high-end cosmetic services within the same practice. The brow-to-cheek aesthetic zone — brow lift, upper blepharoplasty, lower blepharoplasty, periorbital injectables — is one of the most requested cosmetic areas in patients 45–70. Practices that integrate cosmetic Botox and filler (periorbital areas: glabella, forehead, crow's feet, tear troughs, cheek volumization) alongside surgical blepharoplasty create a complete aesthetic continuum with recurring injectable visits driving patient loyalty and a predictable revenue floor between surgical cases.

Geographic variation

• Major academic ophthalmology centers (Wills Eye, Bascom Palmer, MEEI, Kellogg, Jules Stein): $310,000–$510,000; academic model; fellowship training; ASOPRS program prestige
• Urban aesthetic markets (LA, NYC, Miami, Chicago, Dallas): $600,000–$1,200,000; high self-pay capacity; periorbital rejuvenation demand in affluent demographics; competition from high-profile practitioners in these markets
• Sun Belt and retirement markets (FL, AZ, SC, NC coastal): $500,000–$900,000; aging population drives both functional (ptosis, entropion, ectropion) and cosmetic blepharoplasty volume; lower competition than tier-1 aesthetic markets; excellent for establishing dominant market position
• Suburban and secondary markets: $400,000–$700,000; strong functional volume from ophthalmology referrals; cosmetic ceiling lower but overhead costs lower; quality-of-life advantage

What we see at Ava Health

Oculoplastic surgeons respond well to outreach because ASOPRS fellowship supply is thin (120–150 graduates per year) relative to demand, and the specialty has natural mobility — the functional procedure volume (ptosis, blepharoplasty, lacrimal) exists in every market with an ophthalmology base, and the cosmetic upside is market-dependent, making geographic moves attractive when better markets open up. The most sought-after profile in oculoplastic recruiting: ASOPRS-certified surgeons who also have a well-developed cosmetic practice and are open to building or joining a standalone oculoplastic center with direct-pay aesthetics capability alongside functional surgical volume.

Related: Cosmetic Surgeon Salary Guide, Ophthalmologist Salary Guide, Dermatologist Salary Guide, Plastic Surgeon Salary Guide.